Global Artificial Joint Infection Treatment Supply, Demand and Key Producers, 2023-2029
The global Artificial Joint Infection Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Artificial Joint Infection Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Joint Infection Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Joint Infection Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Joint Infection Treatment total market, 2018-2029, (USD Million)
Global Artificial Joint Infection Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Artificial Joint Infection Treatment total market, key domestic companies and share, (USD Million)
Global Artificial Joint Infection Treatment revenue by player and market share 2018-2023, (USD Million)
Global Artificial Joint Infection Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Artificial Joint Infection Treatment total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Artificial Joint Infection Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arrevus, MELINTA THERAPEUTICS, INC., Nabriva Therapeutics plc, Peptilogics, Telephus Medical LLC, TenNor Therapeutics Ltd, Cempra Inc, Motif Bio Plc and Johnson & Johnson Services, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Artificial Joint Infection Treatment market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Artificial Joint Infection Treatment Market, By Region:
1. How big is the global Artificial Joint Infection Treatment market?
2. What is the demand of the global Artificial Joint Infection Treatment market?
3. What is the year over year growth of the global Artificial Joint Infection Treatment market?
4. What is the total value of the global Artificial Joint Infection Treatment market?
5. Who are the major players in the global Artificial Joint Infection Treatment market?
This report studies the global Artificial Joint Infection Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Joint Infection Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Joint Infection Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Joint Infection Treatment total market, 2018-2029, (USD Million)
Global Artificial Joint Infection Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Artificial Joint Infection Treatment total market, key domestic companies and share, (USD Million)
Global Artificial Joint Infection Treatment revenue by player and market share 2018-2023, (USD Million)
Global Artificial Joint Infection Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Artificial Joint Infection Treatment total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Artificial Joint Infection Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arrevus, MELINTA THERAPEUTICS, INC., Nabriva Therapeutics plc, Peptilogics, Telephus Medical LLC, TenNor Therapeutics Ltd, Cempra Inc, Motif Bio Plc and Johnson & Johnson Services, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Artificial Joint Infection Treatment market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Artificial Joint Infection Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Aminoglycosides
- Glycopeptides
- Rifamycin
- Lincosamide
- Penicillin
- Others
- Hospital
- Clinic
- Others
- Arrevus
- MELINTA THERAPEUTICS, INC.
- Nabriva Therapeutics plc
- Peptilogics
- Telephus Medical LLC
- TenNor Therapeutics Ltd
- Cempra Inc
- Motif Bio Plc
- Johnson & Johnson Services
1. How big is the global Artificial Joint Infection Treatment market?
2. What is the demand of the global Artificial Joint Infection Treatment market?
3. What is the year over year growth of the global Artificial Joint Infection Treatment market?
4. What is the total value of the global Artificial Joint Infection Treatment market?
5. Who are the major players in the global Artificial Joint Infection Treatment market?
1 SUPPLY SUMMARY
1.1 Artificial Joint Infection Treatment Introduction
1.2 World Artificial Joint Infection Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Artificial Joint Infection Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Joint Infection Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.3 China Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.4 Europe Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.5 Japan Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.6 South Korea Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.7 ASEAN Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.8 India Artificial Joint Infection Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Joint Infection Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Artificial Joint Infection Treatment Major Market Trends
2 DEMAND SUMMARY
2.1 World Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.2 World Artificial Joint Infection Treatment Consumption Value by Region
2.2.1 World Artificial Joint Infection Treatment Consumption Value by Region (2018-2023)
2.2.2 World Artificial Joint Infection Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.4 China Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.5 Europe Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.6 Japan Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.7 South Korea Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.8 ASEAN Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.9 India Artificial Joint Infection Treatment Consumption Value (2018-2029)
3 WORLD ARTIFICIAL JOINT INFECTION TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Artificial Joint Infection Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Joint Infection Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Joint Infection Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Artificial Joint Infection Treatment in 2022
3.3 Artificial Joint Infection Treatment Company Evaluation Quadrant
3.4 Artificial Joint Infection Treatment Market: Overall Company Footprint Analysis
3.4.1 Artificial Joint Infection Treatment Market: Region Footprint
3.4.2 Artificial Joint Infection Treatment Market: Company Product Type Footprint
3.4.3 Artificial Joint Infection Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Artificial Joint Infection Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Joint Infection Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Artificial Joint Infection Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Artificial Joint Infection Treatment Consumption Value Comparison
4.2.1 United States VS China: Artificial Joint Infection Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Artificial Joint Infection Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Artificial Joint Infection Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Artificial Joint Infection Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023)
4.4 China Based Companies Artificial Joint Infection Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Artificial Joint Infection Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023)
4.5 Rest of World Based Artificial Joint Infection Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Artificial Joint Infection Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Artificial Joint Infection Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Aminoglycosides
5.2.2 Glycopeptides
5.2.3 Rifamycin
5.2.4 Lincosamide
5.2.5 Penicillin
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Artificial Joint Infection Treatment Market Size by Type (2018-2023)
5.3.2 World Artificial Joint Infection Treatment Market Size by Type (2024-2029)
5.3.3 World Artificial Joint Infection Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Artificial Joint Infection Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Artificial Joint Infection Treatment Market Size by Application (2018-2023)
6.3.2 World Artificial Joint Infection Treatment Market Size by Application (2024-2029)
6.3.3 World Artificial Joint Infection Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Arrevus
7.1.1 Arrevus Details
7.1.2 Arrevus Major Business
7.1.3 Arrevus Artificial Joint Infection Treatment Product and Services
7.1.4 Arrevus Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Arrevus Recent Developments/Updates
7.1.6 Arrevus Competitive Strengths & Weaknesses
7.2 MELINTA THERAPEUTICS, INC.
7.2.1 MELINTA THERAPEUTICS, INC. Details
7.2.2 MELINTA THERAPEUTICS, INC. Major Business
7.2.3 MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Product and Services
7.2.4 MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 MELINTA THERAPEUTICS, INC. Recent Developments/Updates
7.2.6 MELINTA THERAPEUTICS, INC. Competitive Strengths & Weaknesses
7.3 Nabriva Therapeutics plc
7.3.1 Nabriva Therapeutics plc Details
7.3.2 Nabriva Therapeutics plc Major Business
7.3.3 Nabriva Therapeutics plc Artificial Joint Infection Treatment Product and Services
7.3.4 Nabriva Therapeutics plc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Nabriva Therapeutics plc Recent Developments/Updates
7.3.6 Nabriva Therapeutics plc Competitive Strengths & Weaknesses
7.4 Peptilogics
7.4.1 Peptilogics Details
7.4.2 Peptilogics Major Business
7.4.3 Peptilogics Artificial Joint Infection Treatment Product and Services
7.4.4 Peptilogics Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Peptilogics Recent Developments/Updates
7.4.6 Peptilogics Competitive Strengths & Weaknesses
7.5 Telephus Medical LLC
7.5.1 Telephus Medical LLC Details
7.5.2 Telephus Medical LLC Major Business
7.5.3 Telephus Medical LLC Artificial Joint Infection Treatment Product and Services
7.5.4 Telephus Medical LLC Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Telephus Medical LLC Recent Developments/Updates
7.5.6 Telephus Medical LLC Competitive Strengths & Weaknesses
7.6 TenNor Therapeutics Ltd
7.6.1 TenNor Therapeutics Ltd Details
7.6.2 TenNor Therapeutics Ltd Major Business
7.6.3 TenNor Therapeutics Ltd Artificial Joint Infection Treatment Product and Services
7.6.4 TenNor Therapeutics Ltd Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 TenNor Therapeutics Ltd Recent Developments/Updates
7.6.6 TenNor Therapeutics Ltd Competitive Strengths & Weaknesses
7.7 Cempra Inc
7.7.1 Cempra Inc Details
7.7.2 Cempra Inc Major Business
7.7.3 Cempra Inc Artificial Joint Infection Treatment Product and Services
7.7.4 Cempra Inc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Cempra Inc Recent Developments/Updates
7.7.6 Cempra Inc Competitive Strengths & Weaknesses
7.8 Motif Bio Plc
7.8.1 Motif Bio Plc Details
7.8.2 Motif Bio Plc Major Business
7.8.3 Motif Bio Plc Artificial Joint Infection Treatment Product and Services
7.8.4 Motif Bio Plc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Motif Bio Plc Recent Developments/Updates
7.8.6 Motif Bio Plc Competitive Strengths & Weaknesses
7.9 Johnson & Johnson Services
7.9.1 Johnson & Johnson Services Details
7.9.2 Johnson & Johnson Services Major Business
7.9.3 Johnson & Johnson Services Artificial Joint Infection Treatment Product and Services
7.9.4 Johnson & Johnson Services Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Johnson & Johnson Services Recent Developments/Updates
7.9.6 Johnson & Johnson Services Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Artificial Joint Infection Treatment Industry Chain
8.2 Artificial Joint Infection Treatment Upstream Analysis
8.3 Artificial Joint Infection Treatment Midstream Analysis
8.4 Artificial Joint Infection Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Artificial Joint Infection Treatment Introduction
1.2 World Artificial Joint Infection Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Artificial Joint Infection Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Joint Infection Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.3 China Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.4 Europe Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.5 Japan Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.6 South Korea Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.7 ASEAN Artificial Joint Infection Treatment Market Size (2018-2029)
1.3.8 India Artificial Joint Infection Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Joint Infection Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Artificial Joint Infection Treatment Major Market Trends
2 DEMAND SUMMARY
2.1 World Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.2 World Artificial Joint Infection Treatment Consumption Value by Region
2.2.1 World Artificial Joint Infection Treatment Consumption Value by Region (2018-2023)
2.2.2 World Artificial Joint Infection Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.4 China Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.5 Europe Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.6 Japan Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.7 South Korea Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.8 ASEAN Artificial Joint Infection Treatment Consumption Value (2018-2029)
2.9 India Artificial Joint Infection Treatment Consumption Value (2018-2029)
3 WORLD ARTIFICIAL JOINT INFECTION TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Artificial Joint Infection Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Joint Infection Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Joint Infection Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Artificial Joint Infection Treatment in 2022
3.3 Artificial Joint Infection Treatment Company Evaluation Quadrant
3.4 Artificial Joint Infection Treatment Market: Overall Company Footprint Analysis
3.4.1 Artificial Joint Infection Treatment Market: Region Footprint
3.4.2 Artificial Joint Infection Treatment Market: Company Product Type Footprint
3.4.3 Artificial Joint Infection Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Artificial Joint Infection Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Joint Infection Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Artificial Joint Infection Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Artificial Joint Infection Treatment Consumption Value Comparison
4.2.1 United States VS China: Artificial Joint Infection Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Artificial Joint Infection Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Artificial Joint Infection Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Artificial Joint Infection Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023)
4.4 China Based Companies Artificial Joint Infection Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Artificial Joint Infection Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023)
4.5 Rest of World Based Artificial Joint Infection Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Artificial Joint Infection Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Artificial Joint Infection Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Aminoglycosides
5.2.2 Glycopeptides
5.2.3 Rifamycin
5.2.4 Lincosamide
5.2.5 Penicillin
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Artificial Joint Infection Treatment Market Size by Type (2018-2023)
5.3.2 World Artificial Joint Infection Treatment Market Size by Type (2024-2029)
5.3.3 World Artificial Joint Infection Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Artificial Joint Infection Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Artificial Joint Infection Treatment Market Size by Application (2018-2023)
6.3.2 World Artificial Joint Infection Treatment Market Size by Application (2024-2029)
6.3.3 World Artificial Joint Infection Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Arrevus
7.1.1 Arrevus Details
7.1.2 Arrevus Major Business
7.1.3 Arrevus Artificial Joint Infection Treatment Product and Services
7.1.4 Arrevus Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Arrevus Recent Developments/Updates
7.1.6 Arrevus Competitive Strengths & Weaknesses
7.2 MELINTA THERAPEUTICS, INC.
7.2.1 MELINTA THERAPEUTICS, INC. Details
7.2.2 MELINTA THERAPEUTICS, INC. Major Business
7.2.3 MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Product and Services
7.2.4 MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 MELINTA THERAPEUTICS, INC. Recent Developments/Updates
7.2.6 MELINTA THERAPEUTICS, INC. Competitive Strengths & Weaknesses
7.3 Nabriva Therapeutics plc
7.3.1 Nabriva Therapeutics plc Details
7.3.2 Nabriva Therapeutics plc Major Business
7.3.3 Nabriva Therapeutics plc Artificial Joint Infection Treatment Product and Services
7.3.4 Nabriva Therapeutics plc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Nabriva Therapeutics plc Recent Developments/Updates
7.3.6 Nabriva Therapeutics plc Competitive Strengths & Weaknesses
7.4 Peptilogics
7.4.1 Peptilogics Details
7.4.2 Peptilogics Major Business
7.4.3 Peptilogics Artificial Joint Infection Treatment Product and Services
7.4.4 Peptilogics Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Peptilogics Recent Developments/Updates
7.4.6 Peptilogics Competitive Strengths & Weaknesses
7.5 Telephus Medical LLC
7.5.1 Telephus Medical LLC Details
7.5.2 Telephus Medical LLC Major Business
7.5.3 Telephus Medical LLC Artificial Joint Infection Treatment Product and Services
7.5.4 Telephus Medical LLC Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Telephus Medical LLC Recent Developments/Updates
7.5.6 Telephus Medical LLC Competitive Strengths & Weaknesses
7.6 TenNor Therapeutics Ltd
7.6.1 TenNor Therapeutics Ltd Details
7.6.2 TenNor Therapeutics Ltd Major Business
7.6.3 TenNor Therapeutics Ltd Artificial Joint Infection Treatment Product and Services
7.6.4 TenNor Therapeutics Ltd Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 TenNor Therapeutics Ltd Recent Developments/Updates
7.6.6 TenNor Therapeutics Ltd Competitive Strengths & Weaknesses
7.7 Cempra Inc
7.7.1 Cempra Inc Details
7.7.2 Cempra Inc Major Business
7.7.3 Cempra Inc Artificial Joint Infection Treatment Product and Services
7.7.4 Cempra Inc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Cempra Inc Recent Developments/Updates
7.7.6 Cempra Inc Competitive Strengths & Weaknesses
7.8 Motif Bio Plc
7.8.1 Motif Bio Plc Details
7.8.2 Motif Bio Plc Major Business
7.8.3 Motif Bio Plc Artificial Joint Infection Treatment Product and Services
7.8.4 Motif Bio Plc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Motif Bio Plc Recent Developments/Updates
7.8.6 Motif Bio Plc Competitive Strengths & Weaknesses
7.9 Johnson & Johnson Services
7.9.1 Johnson & Johnson Services Details
7.9.2 Johnson & Johnson Services Major Business
7.9.3 Johnson & Johnson Services Artificial Joint Infection Treatment Product and Services
7.9.4 Johnson & Johnson Services Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Johnson & Johnson Services Recent Developments/Updates
7.9.6 Johnson & Johnson Services Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Artificial Joint Infection Treatment Industry Chain
8.2 Artificial Joint Infection Treatment Upstream Analysis
8.3 Artificial Joint Infection Treatment Midstream Analysis
8.4 Artificial Joint Infection Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Artificial Joint Infection Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Joint Infection Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Joint Infection Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Joint Infection Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Artificial Joint Infection Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Joint Infection Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Artificial Joint Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Artificial Joint Infection Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Artificial Joint Infection Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Joint Infection Treatment Players in 2022
Table 12. World Artificial Joint Infection Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Artificial Joint Infection Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Joint Infection Treatment Player
Table 15. Artificial Joint Infection Treatment Market: Company Product Type Footprint
Table 16. Artificial Joint Infection Treatment Market: Company Product Application Footprint
Table 17. Artificial Joint Infection Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Joint Infection Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Artificial Joint Infection Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Artificial Joint Infection Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Artificial Joint Infection Treatment Revenue Market Share (2018-2023)
Table 23. China Based Artificial Joint Infection Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Artificial Joint Infection Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Artificial Joint Infection Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Artificial Joint Infection Treatment Revenue Market Share (2018-2023)
Table 29. World Artificial Joint Infection Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Artificial Joint Infection Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Artificial Joint Infection Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Artificial Joint Infection Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Artificial Joint Infection Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Artificial Joint Infection Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. Arrevus Basic Information, Area Served and Competitors
Table 36. Arrevus Major Business
Table 37. Arrevus Artificial Joint Infection Treatment Product and Services
Table 38. Arrevus Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Arrevus Recent Developments/Updates
Table 40. Arrevus Competitive Strengths & Weaknesses
Table 41. MELINTA THERAPEUTICS, INC. Basic Information, Area Served and Competitors
Table 42. MELINTA THERAPEUTICS, INC. Major Business
Table 43. MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Product and Services
Table 44. MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. MELINTA THERAPEUTICS, INC. Recent Developments/Updates
Table 46. MELINTA THERAPEUTICS, INC. Competitive Strengths & Weaknesses
Table 47. Nabriva Therapeutics plc Basic Information, Area Served and Competitors
Table 48. Nabriva Therapeutics plc Major Business
Table 49. Nabriva Therapeutics plc Artificial Joint Infection Treatment Product and Services
Table 50. Nabriva Therapeutics plc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Nabriva Therapeutics plc Recent Developments/Updates
Table 52. Nabriva Therapeutics plc Competitive Strengths & Weaknesses
Table 53. Peptilogics Basic Information, Area Served and Competitors
Table 54. Peptilogics Major Business
Table 55. Peptilogics Artificial Joint Infection Treatment Product and Services
Table 56. Peptilogics Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Peptilogics Recent Developments/Updates
Table 58. Peptilogics Competitive Strengths & Weaknesses
Table 59. Telephus Medical LLC Basic Information, Area Served and Competitors
Table 60. Telephus Medical LLC Major Business
Table 61. Telephus Medical LLC Artificial Joint Infection Treatment Product and Services
Table 62. Telephus Medical LLC Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Telephus Medical LLC Recent Developments/Updates
Table 64. Telephus Medical LLC Competitive Strengths & Weaknesses
Table 65. TenNor Therapeutics Ltd Basic Information, Area Served and Competitors
Table 66. TenNor Therapeutics Ltd Major Business
Table 67. TenNor Therapeutics Ltd Artificial Joint Infection Treatment Product and Services
Table 68. TenNor Therapeutics Ltd Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. TenNor Therapeutics Ltd Recent Developments/Updates
Table 70. TenNor Therapeutics Ltd Competitive Strengths & Weaknesses
Table 71. Cempra Inc Basic Information, Area Served and Competitors
Table 72. Cempra Inc Major Business
Table 73. Cempra Inc Artificial Joint Infection Treatment Product and Services
Table 74. Cempra Inc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Cempra Inc Recent Developments/Updates
Table 76. Cempra Inc Competitive Strengths & Weaknesses
Table 77. Motif Bio Plc Basic Information, Area Served and Competitors
Table 78. Motif Bio Plc Major Business
Table 79. Motif Bio Plc Artificial Joint Infection Treatment Product and Services
Table 80. Motif Bio Plc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Motif Bio Plc Recent Developments/Updates
Table 82. Johnson & Johnson Services Basic Information, Area Served and Competitors
Table 83. Johnson & Johnson Services Major Business
Table 84. Johnson & Johnson Services Artificial Joint Infection Treatment Product and Services
Table 85. Johnson & Johnson Services Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Artificial Joint Infection Treatment Upstream (Raw Materials)
Table 87. Artificial Joint Infection Treatment Typical Customers
List of Figure
Figure 1. Artificial Joint Infection Treatment Picture
Figure 2. World Artificial Joint Infection Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Artificial Joint Infection Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Artificial Joint Infection Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Artificial Joint Infection Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Artificial Joint Infection Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Artificial Joint Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Artificial Joint Infection Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Joint Infection Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Joint Infection Treatment Markets in 2022
Figure 27. United States VS China: Artificial Joint Infection Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Artificial Joint Infection Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Artificial Joint Infection Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Artificial Joint Infection Treatment Market Size Market Share by Type in 2022
Figure 31. Aminoglycosides
Figure 32. Glycopeptides
Figure 33. Rifamycin
Figure 34. Lincosamide
Figure 35. Penicillin
Figure 36. Others
Figure 37. World Artificial Joint Infection Treatment Market Size Market Share by Type (2018-2029)
Figure 38. World Artificial Joint Infection Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 39. World Artificial Joint Infection Treatment Market Size Market Share by Application in 2022
Figure 40. Hospital
Figure 41. Clinic
Figure 42. Others
Figure 43. Artificial Joint Infection Treatment Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Table 1. World Artificial Joint Infection Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Joint Infection Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Joint Infection Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Joint Infection Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Artificial Joint Infection Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Joint Infection Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Artificial Joint Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Artificial Joint Infection Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Artificial Joint Infection Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Joint Infection Treatment Players in 2022
Table 12. World Artificial Joint Infection Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Artificial Joint Infection Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Joint Infection Treatment Player
Table 15. Artificial Joint Infection Treatment Market: Company Product Type Footprint
Table 16. Artificial Joint Infection Treatment Market: Company Product Application Footprint
Table 17. Artificial Joint Infection Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Joint Infection Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Artificial Joint Infection Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Artificial Joint Infection Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Artificial Joint Infection Treatment Revenue Market Share (2018-2023)
Table 23. China Based Artificial Joint Infection Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Artificial Joint Infection Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Artificial Joint Infection Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Artificial Joint Infection Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Artificial Joint Infection Treatment Revenue Market Share (2018-2023)
Table 29. World Artificial Joint Infection Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Artificial Joint Infection Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Artificial Joint Infection Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Artificial Joint Infection Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Artificial Joint Infection Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Artificial Joint Infection Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. Arrevus Basic Information, Area Served and Competitors
Table 36. Arrevus Major Business
Table 37. Arrevus Artificial Joint Infection Treatment Product and Services
Table 38. Arrevus Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Arrevus Recent Developments/Updates
Table 40. Arrevus Competitive Strengths & Weaknesses
Table 41. MELINTA THERAPEUTICS, INC. Basic Information, Area Served and Competitors
Table 42. MELINTA THERAPEUTICS, INC. Major Business
Table 43. MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Product and Services
Table 44. MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. MELINTA THERAPEUTICS, INC. Recent Developments/Updates
Table 46. MELINTA THERAPEUTICS, INC. Competitive Strengths & Weaknesses
Table 47. Nabriva Therapeutics plc Basic Information, Area Served and Competitors
Table 48. Nabriva Therapeutics plc Major Business
Table 49. Nabriva Therapeutics plc Artificial Joint Infection Treatment Product and Services
Table 50. Nabriva Therapeutics plc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Nabriva Therapeutics plc Recent Developments/Updates
Table 52. Nabriva Therapeutics plc Competitive Strengths & Weaknesses
Table 53. Peptilogics Basic Information, Area Served and Competitors
Table 54. Peptilogics Major Business
Table 55. Peptilogics Artificial Joint Infection Treatment Product and Services
Table 56. Peptilogics Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Peptilogics Recent Developments/Updates
Table 58. Peptilogics Competitive Strengths & Weaknesses
Table 59. Telephus Medical LLC Basic Information, Area Served and Competitors
Table 60. Telephus Medical LLC Major Business
Table 61. Telephus Medical LLC Artificial Joint Infection Treatment Product and Services
Table 62. Telephus Medical LLC Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Telephus Medical LLC Recent Developments/Updates
Table 64. Telephus Medical LLC Competitive Strengths & Weaknesses
Table 65. TenNor Therapeutics Ltd Basic Information, Area Served and Competitors
Table 66. TenNor Therapeutics Ltd Major Business
Table 67. TenNor Therapeutics Ltd Artificial Joint Infection Treatment Product and Services
Table 68. TenNor Therapeutics Ltd Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. TenNor Therapeutics Ltd Recent Developments/Updates
Table 70. TenNor Therapeutics Ltd Competitive Strengths & Weaknesses
Table 71. Cempra Inc Basic Information, Area Served and Competitors
Table 72. Cempra Inc Major Business
Table 73. Cempra Inc Artificial Joint Infection Treatment Product and Services
Table 74. Cempra Inc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Cempra Inc Recent Developments/Updates
Table 76. Cempra Inc Competitive Strengths & Weaknesses
Table 77. Motif Bio Plc Basic Information, Area Served and Competitors
Table 78. Motif Bio Plc Major Business
Table 79. Motif Bio Plc Artificial Joint Infection Treatment Product and Services
Table 80. Motif Bio Plc Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Motif Bio Plc Recent Developments/Updates
Table 82. Johnson & Johnson Services Basic Information, Area Served and Competitors
Table 83. Johnson & Johnson Services Major Business
Table 84. Johnson & Johnson Services Artificial Joint Infection Treatment Product and Services
Table 85. Johnson & Johnson Services Artificial Joint Infection Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Artificial Joint Infection Treatment Upstream (Raw Materials)
Table 87. Artificial Joint Infection Treatment Typical Customers
List of Figure
Figure 1. Artificial Joint Infection Treatment Picture
Figure 2. World Artificial Joint Infection Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Artificial Joint Infection Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Artificial Joint Infection Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Artificial Joint Infection Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Artificial Joint Infection Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Artificial Joint Infection Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Artificial Joint Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Artificial Joint Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Artificial Joint Infection Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Joint Infection Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Joint Infection Treatment Markets in 2022
Figure 27. United States VS China: Artificial Joint Infection Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Artificial Joint Infection Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Artificial Joint Infection Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Artificial Joint Infection Treatment Market Size Market Share by Type in 2022
Figure 31. Aminoglycosides
Figure 32. Glycopeptides
Figure 33. Rifamycin
Figure 34. Lincosamide
Figure 35. Penicillin
Figure 36. Others
Figure 37. World Artificial Joint Infection Treatment Market Size Market Share by Type (2018-2029)
Figure 38. World Artificial Joint Infection Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 39. World Artificial Joint Infection Treatment Market Size Market Share by Application in 2022
Figure 40. Hospital
Figure 41. Clinic
Figure 42. Others
Figure 43. Artificial Joint Infection Treatment Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
